Investors: Together let’s transform the lives of families affected by Alzheimer’s disease
Alzheimer’s disease is currently one of the greatest public health challenges worlwide.
At Synaptys neuroscience, we are at the forefront of research to slow down, or even stop, this disease through our innovation, SYS-0108.
After more than 13 years of research and with a dedicated team of scientists, we have reached crucial milestones in the development of our therapeutic solution.
By supporting SYNAPTYS neuroscience, you help us accelerate the clinical phase and contribute not only to improving the quality of life for patients but also to making an investment with significant economic and social impact. The demand for effective treatments for neurodegenerative diseases is constantly increasing, and our multidisciplinary approach, utilizing molecular synergies and artificial intelligence, places SYNAPTYS neuroscience at the forefront of this battle.
A major medical and societal impact
Our treatment for Alzheimer’s could change the lives of millions of people.
A rapidly growing market
The need for therapeutic solutions for neurodegenerative disease and the number of patients continue to grow..
Economic benefits
Our innovation helps to:
– Reduce costs related to long-term care and hospitalizations.
– Lessen the financial burden on healthcare systems.
To receive our investor documentation, please provide your contact details: